BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34771483)

  • 1. Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?
    Ciciarello M; Corradi G; Forte D; Cavo M; Curti A
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs Activity in the Leukemic Bone Marrow Microenvironment.
    Liccardo F; Iaiza A; Śniegocka M; Masciarelli S; Fazi F
    Noncoding RNA; 2022 Jul; 8(4):. PubMed ID: 35893233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies.
    Tomasoni C; Pievani A; Rambaldi B; Biondi A; Serafini M
    Hemasphere; 2023 Jun; 7(6):e896. PubMed ID: 37234820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche.
    Fallati A; Di Marzo N; D'Amico G; Dander E
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
    Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location First: Targeting Acute Myeloid Leukemia Within Its Niche.
    Pievani A; Biondi M; Tomasoni C; Biondi A; Serafini M
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32443460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
    Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
    Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia.
    Ciciarello M; Corradi G; Loscocco F; Visani G; Monaco F; Cavo M; Curti A; Isidori A
    Front Oncol; 2019; 9():1135. PubMed ID: 31709192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
    Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
    Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
    Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
    Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bone marrow microenvironment - Home of the leukemic blasts.
    Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
    Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
    Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
    J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
    Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.
    Portale F; Cricrì G; Bresolin S; Lupi M; Gaspari S; Silvestri D; Russo B; Marino N; Ubezio P; Pagni F; Vergani P; Kronnie GT; Valsecchi MG; Locatelli F; Rizzari C; Biondi A; Dander E; D'Amico G
    Haematologica; 2019 Mar; 104(3):533-545. PubMed ID: 30262563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.
    Wu CH; Weng TF; Li JP; Wu KH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
    Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
    Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.